Friday, Amedisys Inc. (AMED), provider of home health and hospice services, reaffirmed its guidance for the full year.
Amedisys' reiterated its full-year earnings outlook in the range of $4.75-$4.90 per share, excluding the effects of any possible future acquisitions. The company also backed its service revenue guidance in the range of $1.475 billion to $1.5 billion, for the year.
On average, Analysts polled by Thomson Reuters expect Amedisys to report profit of $4.84 per share for the full year on revenues of $1.5 billion. Analysts typically exclude one-time items.
In July, the company had raised its earnings guidance to the current range of $4.75-$4.90 per share from $4.10 - $4.30 per share issued in January.
AMED is currently trading at $34.04 on Nasdaq.
For comments and feedback: editorial@rttnews.com